agilon health, inc. Income (Loss) from Equity Method Investments
agilon health, inc. (AGL) reported Income (Loss) from Equity Method Investments of -$7.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-05
- agilon health, inc. income (loss) from equity method investments for the quarter ending 2026-06-30 was -$7.60M, a 240.35% decline year-over-year.
- agilon health, inc. income (loss) from equity method investments for the quarter ending 2026-03-31 was $11.73M, a 7.41% decline year-over-year.
- agilon health, inc. income (loss) from equity method investments for the quarter ending 2025-12-31 was -$33.05M.
- agilon health, inc. income (loss) from equity method investments for the quarter ending 2025-09-30 was $13.13M, a 541.57% increase year-over-year.
- agilon health, inc. income (loss) from equity method investments for fiscal 2025 was -$1.83M, a 112.24% decline from fiscal 2024.
- agilon health, inc. income (loss) from equity method investments for fiscal 2024 was $14.99M, a 9.08% decline from fiscal 2023.
- agilon health, inc. income (loss) from equity method investments for fiscal 2023 was $16.49M, a 53.82% increase from fiscal 2022.
- agilon health, inc. income (loss) from equity method investments for fiscal 2022 was $10.72M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.60M 10-Q · filed 2026-08-05 | $4.14M 10-Q · filed 2026-08-05 | -$28.91M derived: sum of 3 quarters · filed 2026-08-05 | -$15.78M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $11.73M 10-Q · filed 2026-05-06 | -$21.32M derived: sum of 2 quarters · filed 2026-05-06 | -$8.19M derived: sum of 3 quarters · filed 2026-05-06 | -$2.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$33.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$19.92M derived: sum of 2 quarters · filed 2026-02-25 | -$14.51M derived: sum of 3 quarters · filed 2026-08-05 | -$1.83M 10-K · filed 2026-02-25 |
| 2025-09-30 | $13.13M 10-Q · filed 2025-11-04 | $18.55M derived: sum of 2 quarters · filed 2026-08-05 | $31.22M 10-Q · filed 2025-11-04 | $28.52M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $5.41M 10-Q · filed 2026-08-05 | $18.08M 10-Q · filed 2026-08-05 | $15.39M derived: sum of 3 quarters · filed 2026-08-05 | $17.44M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $12.67M 10-Q · filed 2026-05-06 | $9.98M derived: sum of 2 quarters · filed 2026-05-06 | $12.03M derived: sum of 3 quarters · filed 2026-05-06 | $21.98M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$647.00K derived: sum of 2 quarters · filed 2026-02-25 | $9.31M derived: sum of 3 quarters · filed 2026-02-25 | $14.99M 10-K · filed 2026-02-25 |
| 2024-09-30 | $2.05M 10-Q · filed 2025-11-04 | $12.00M derived: sum of 2 quarters · filed 2025-11-04 | $17.69M 10-Q · filed 2025-11-04 | $9.67M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $9.96M 10-Q · filed 2025-08-04 | $15.64M 10-Q · filed 2025-08-04 | $7.62M derived: sum of 3 quarters · filed 2026-02-25 | $22.28M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $5.68M 10-Q · filed 2025-05-06 | -$2.33M derived: sum of 2 quarters · filed 2026-02-25 | $12.32M derived: sum of 3 quarters · filed 2026-02-25 | $20.80M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$8.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.64M derived: sum of 2 quarters · filed 2026-02-25 | $15.11M derived: sum of 3 quarters · filed 2026-02-25 | $16.49M 10-K · filed 2026-02-25 |
| 2023-09-30 | $14.66M 10-Q · filed 2024-11-07 | $23.13M derived: sum of 2 quarters · filed 2024-11-07 | $24.51M 10-Q · filed 2024-11-07 | $31.75M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $8.47M 10-Q · filed 2024-08-06 | $9.85M 10-Q · filed 2024-08-06 | $17.09M derived: sum of 3 quarters · filed 2025-02-25 | $12.78M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $1.38M 10-Q · filed 2024-05-07 | $8.62M derived: sum of 2 quarters · filed 2025-02-25 | $4.31M derived: sum of 3 quarters · filed 2025-02-25 | $10.06M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.93M derived: sum of 2 quarters · filed 2025-02-25 | $8.69M derived: sum of 3 quarters · filed 2025-02-25 | $10.72M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$4.31M 10-Q · filed 2023-11-02 | $1.44M derived: sum of 2 quarters · filed 2023-11-02 | $3.47M 10-Q · filed 2023-11-02 | $12.37M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $5.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $7.79M 10-Q · filed 2023-08-03 | $16.69M derived: sum of 3 quarters · filed 2023-08-03 | $16.23M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $2.03M 10-Q · filed 2023-05-09 | $10.93M derived: sum of 2 quarters · filed 2023-05-09 | $10.48M derived: sum of 3 quarters · filed 2023-05-09 | $13.02M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $8.90M 10-K · filed 2022-03-03 | $8.45M derived: sum of 2 quarters · filed 2022-11-03 | $10.98M derived: sum of 3 quarters · filed 2022-11-03 | -$6.77M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$452.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.08M derived: sum of 2 quarters · filed 2022-11-03 | $2.08M 10-Q · filed 2022-11-03 | $2.56M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.53M 10-Q · filed 2022-08-04 | $3.01M derived: sum of 3 quarters · filed 2023-03-01 | $2.67M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$3.00K 10-Q · filed 2022-05-05 | $478.00K derived: sum of 2 quarters · filed 2023-03-01 | $131.00K derived: sum of 3 quarters · filed 2023-03-01 | |
| 2020-12-31 | $481.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $134.00K derived: sum of 2 quarters · filed 2023-03-01 | $514.00K 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$347.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $33.00K 10-Q · filed 2021-10-28 | ||
| 2020-06-30 | $380.00K 10-Q · filed 2021-08-04 | |||
| 2019-12-31 | -$747.00K 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |